Sapphiros and binx health Combine to Form Onvaro
Diagnostics platform Sapphiros, backed by KKR-managed funds, has combined with binx health to form a new diagnostics company called Onvaro.
Stocks · News reference
The surviving company will focus on innovation in its fixed-line, media, and enterprise businesses, while the newly established company will aim to expand Korea’s leading AI data center (AIDC) infrastructure. Based on
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Diagnostics platform Sapphiros, backed by KKR-managed funds, has combined with binx health to form a new diagnostics company called Onvaro.
KKR has published an 'Asset-Based Finance Overview' presentation on its investor relations website.
KKR's acquisition vehicle, Bidco, provided a regulatory update regarding the ongoing recommended all-cash acquisition of Eleco PLC.
Realty Income delivered solid Q3 2026 earnings with 3.7% AFFO per share growth, 98.8% occupancy, and a well-covered dividend, but the stock hasn't surged due to modest earnings growth at its large scale. Despite strong operational metrics and a 5.6% dividend yield, the REIT's limited growth potential and interest rate headwinds constrain stock appreciation, though it remains an attractive income investment for steady double-digit returns.
Realty Income reported Q3 2026 earnings with AFFO up 3.7% to $1.12 per share and raised full-year guidance to $4.45-$4.46. The REIT maintains a 73% dividend payout ratio, invested $2.6 billion in the quarter at 6.8% yield, and continues its 56-year streak of consecutive monthly dividends supported by a diversified tenant base and 96%+ occupancy rates.
KKR is among the leading global investment institutions set to participate in the inaugural New Asia Forum in Bali, Indonesia, in December 2026.